Task: Answer Verification
Input (English): Question: Does the experimental neuroprotectant leukaemia inhibitory factor ( LIF ) compromise antitumour activity of paclitaxel , cisplatin and carboplatin?
Answer: These results suggest that LIF may be safely used in human trials as a neuroprotectant for patients receiving cisplatin, paclitaxel and carboplatin without concern for impairment of antitumour effect.
Output (English): no